Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,036 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 965
Recruiting: 553
Ph III recruiting: 55
Growth YoY: +9.2%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (701)

clinicaltrialsPublishedShowing 201–250 of 654 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06594445	HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML	recruiting	Phase 1	45	Masonic Cancer Center, University of MinnesotaOTHER	1	Jul 14, 2026	clinicaltrials
NCT06480591	Evaluation of the Pathobiology of CALR-mutated MPN Cells	recruiting	—	35	Wake Forest University Health SciencesOTHER	1	Jul 13, 2026	clinicaltrials